NCT04603248

A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

CompletedNAINTERVENTIONAL

Trial Details

Start: 2020-12-03Est. Completion: 2026-03-18

Enrollment target: 50 participants

Locations

EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor

This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Ad…

Seoul, South KoreaEst. completion Jun 2027

CancerHead and Neck Squamous Cell CarcinomaHead and Neck Cancer

This research study will include patients with high risk locally advanced head and neck squamous cell carcinoma (LA-HNSC…

Toronto, CanadaEst. completion Mar 31, 2023

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.